Ovarian clear cell tumor
MONDO:0021144A benign, borderline, or malignant epithelial tumor of the ovary that is characterized by a predominance of clear and hobnail cells.
Also known as: ovarian clear cell neoplasm, ovarian clear cell tumor, clear cell ovarian cancer
1483 clinical trials for this condition and its sub-types, 7 tagged with Ovarian clear cell tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Ovarian clear cell tumor
-
Ovarian clear cell cancer 30 trials · 51 incl. sub-types
2 sub-types
- Ovarian clear cell adenocarcinoma 22 trials · 26 incl. sub-types Sub-types →
- Ovarian clear cell malignant adenofibroma 2 trials
Most studied deeper sub-types
-
Could a natural pill prevent blood clots in ovarian cancer patients?
Disease control Recruiting nowThis study tests whether a daily pill called isoquercetin, made from a plant compound, can reduce blood markers linked to clot risk in people with ovarian cancer. About 90 participants receiving chemotherapy will take either isoquercetin or a placebo for up to 6 weeks. The goal i…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for rare cancers: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two drugs, nilotinib (a pill) and paclitaxel (given by IV), for people with rare advanced cancers that have not responded to standard treatments. The goal is to see if the drugs can shrink or stop tumor growth. About 82 adults with specific rare …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo takes on tough cancers in early trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called BMS-986488, alone or combined with other cancer drugs, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. About 437 adults w…
Phase 1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC